Key Clinical Research

We regularly conduct research and clinical trials in conjunction with the Grand Rapids Clinical Oncology Program (GRCOP) and with funding from the National Cancer Institute (NCI) Community Clinical Oncology Program (CCOP). This means that we partner with 300 physicians to access almost 150 cancer research studies for patients living in 38 counties.

Current Research. Currently, we are the only facility in West Michigan offering the MammoSite Radiation Therapy System (RTS) or Partial Breast Radiation (PBI) clinical trial.  This trial is designed to test whether PBI (radiation therapy that treats only the portion of breast where the tumor is located) is a safe alternative to conventional whole breast radiation. Typically, PBI is offered either through a MammoSite balloon device—a balloon that is inserted into the cavity and delivers high-dose radiation twice daily—or from a linear accelerator, a machine that delivers radiation to the entire breast. Both therapies are given over a one-week period, as opposed to a typical six-week course of radiation therapy. The decision to enroll patients in this trial is typically made after a consultation with a radiation oncologist and surgeon.

In addition, our radiation oncology department is involved in research to identify the clinical benefits of Intensity Modulated Radiation Therapy (IMRT). And, we also participate in clinical trials offered by the Radiation Therapy Oncology Group (RTOG).

Breast Cancer patients who are interested in joining this clinical trial should contact Dr. Gil Padula's office at (616) 752-6218.